title: Circadian rhythm characteristics of oral squamous cell carcinoma growth in an orthotopic xenograft model.
abstract: BACKGROUND
  Recent studies show that circadian rhythm changes are closely related to the occurrence and development of various tumors, such as breast, liver, and prostate. However, there are significant differences in circadian rhythm between different tumors. At present, the circadian rhythm characteristics of oral cancer remain unknown. The purpose of this study is to investigate the circadian rhythm characteristics of the in vivo growth of oral squamous cell carcinoma (OSCC).
  
  
  METHODS
  Thirty-two nude mice were placed under 12-hour light/12-hour dark cycles. The human OSCC cell line BcaCD885 was inoculated in the cheek of nude mice. After 3 weeks, eight mice were sacrificed at four time points, including 4 hours after light onset (HALO), 10 HALO, 16 HALO, and 22 HALO, during a period of 24 hours. The volume of excised tumors was measured and the proliferative index (PI) and apoptotic index (AI) of tumor cells were determined by flow cytometry. A cosine analysis method was used to determine whether the tumor volume, PI, and AI obeyed a circadian rhythm.
  
  
  RESULTS
  There was a significant circadian rhythm in the tumor volume and PI of OSCC cells. For the tumor volume, there were significant differences between the four time points. The peak and trough values of the tumor volume appeared at 3.23 HALO and 15.23 HALO, whereas the peak and trough values of PI appeared at 6.60 HALO and 18.16 HALO, respectively. However, there was no circadian rhythm in the AI of tumor cells, despite significant differences between the four time points.
  
  
  CONCLUSIONS
  This study demonstrates, for the first time, that the tumor volume and PI of in vivo growing OSCC undergo circadian rhythms. These results support the assertion that time factor should be considered in the occurrence, development, treatment, efficacy evaluation and pathophysiology of OSCC.
authors: Department of Oral and Maxillofacial Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
authors: Ningbo
authors: N
authors: Zhao
authors: Hong
authors: H
authors: Tang
authors: Kai
authors: K
authors: Yang
authors: Dan
authors: D
authors: Chen
keywords: apoptosis; oral carcinoma; proliferation
references: Eur J Cancer. 2011 Jul;47(11):1747-58
references: 21459569
references: J Clin Neurophysiol. 1996 Jan;13(1):2-16
references: 8988282
references: Psychoneuroendocrinology. 2010 Aug;35(7):963-76
references: 20097011
references: Cancer Causes Control. 2006 May;17(4):515-23
references: 16596305
references: J Oral Maxillofac Surg. 2005 Nov;63(11):1599-605
references: 16243176
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: Int J Nanomedicine. 2011;6:1739-45
references: 21980236
references: Brain Behav Immun. 2003 Oct;17(5):321-8
references: 12946654
references: Adv Drug Deliv Rev. 2007 Aug 31;59(9-10):828-51
references: 17884237
references: Integr Cancer Ther. 2009 Dec;8(4):298-302
references: 20042408
references: Oral Oncol. 2010 Dec;46(12):864-8
references: 21051276
references: J Int Med Res. 2011;39(6):2061-6
references: 22289520
references: Cell Physiol Biochem. 2010;26(2):155-66
references: 20798499
references: Adv Drug Deliv Rev. 2007 Aug 31;59(9-10):825-7
references: 17825947
references: Adv Drug Deliv Rev. 2010 Jul 31;62(9-10):979-1001
references: 20600409
references: Am J Pathol. 2001 May;158(5):1793-801
references: 11337377
references: Cancer Causes Control. 2006 May;17(4):611-21
references: 16596317
references: J Oral Maxillofac Surg. 2008 Oct;66(10):2151-7
references: 18848117
references: Pol J Pharmacol. 2004 Jan-Feb;56(1):79-84
references: 15047981
references: Mol Cell. 2006 May 5;22(3):375-82
references: 16678109
references: Annu Rev Pharmacol Toxicol. 2010;50:377-421
references: 20055686
references: Nat Rev Cancer. 2003 May;3(5):350-61
references: 12724733
references: Singapore Med J. 2005 Apr;46(4):184-8
references: 15800725
references: Ann N Y Acad Sci. 1991;618:257-76
references: 2006788
references: Lancet Oncol. 2001 May;2(5):307-15
references: 11905786